List of Figures:
Figure 1. Research Method Flow Chart 10
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 13
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 15
Figure 4. Industry Value Chain Analysis 17
Figure 5. North America Hemodynamic Monitoring Systems Market, 2021-2031, $ mn 18
Figure 6. Impact of COVID-19 on Business 21
Figure 7. Primary Drivers and Impact Factors of North America Hemodynamic Monitoring Systems Market 23
Figure 8. Worldwide Prevalence of Cardiovascular Disorders, 1990-2019, million 26
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 29
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 29
Figure 11. Primary Restraints and Impact Factors of North America Hemodynamic Monitoring Systems Market 31
Figure 12. Investment Opportunity Analysis 35
Figure 13. Porter’s Fiver Forces Analysis of North America Hemodynamic Monitoring Systems Market 38
Figure 14. Breakdown of North America Hemodynamic Monitoring Systems Market by Component, 2021-2031, % of Revenue 43
Figure 15. North America Addressable Market Cap in 2022-2031 by Component, Value ($ mn) and Share (%) 43
Figure 16. North America Hemodynamic Monitoring Systems Market by Component: Catheters, 2021-2031, $ mn 44
Figure 17. North America Hemodynamic Monitoring Systems Market by Component: Sensors, 2021-2031, $ mn 45
Figure 18. North America Hemodynamic Monitoring Systems Market by Component: Monitoring Devices, 2021-2031, $ mn 46
Figure 19. North America Hemodynamic Monitoring Systems Market by Component: Probes, 2021-2031, $ mn 47
Figure 20. North America Hemodynamic Monitoring Systems Market by Component: Other Components, 2021-2031, $ mn 48
Figure 21. Breakdown of North America Hemodynamic Monitoring Systems Market by Modality, 2021-2031, % of Sales Revenue 50
Figure 22. North America Addressable Market Cap in 2022-2031 by Modality, Value ($ mn) and Share (%) 50
Figure 23. North America Hemodynamic Monitoring Systems Market by Modality: Invasive Monitoring, 2021-2031, $ mn 51
Figure 24. North America Hemodynamic Monitoring Systems Market by Modality: Minimally Invasive Monitoring, 2021-2031, $ mn 52
Figure 25. North America Hemodynamic Monitoring Systems Market by Modality: Non-Invasive Monitoring, 2021-2031, $ mn 53
Figure 26. Breakdown of North America Hemodynamic Monitoring Systems Market by Setting, 2021-2031, % of Sales Revenue 55
Figure 27. North America Addressable Market Cap in 2022-2031 by Setting, Value ($ mn) and Share (%) 55
Figure 28. North America Hemodynamic Monitoring Systems Market by Setting: Hospitals, 2021-2031, $ mn 56
Figure 29. North America Hemodynamic Monitoring Systems Market by Setting: Clinics, 2021-2031, $ mn 57
Figure 30. North America Hemodynamic Monitoring Systems Market by Setting: Ambulatory Care Units, 2021-2031, $ mn 58
Figure 31. North America Hemodynamic Monitoring Systems Market by Setting: Homecare, 2021-2031, $ mn 59
Figure 32. North America Hemodynamic Monitoring Systems Market by Setting: Other Settings, 2021-2031, $ mn 60
Figure 33. Breakdown of North America Hemodynamic Monitoring Systems Market by Country, 2021 and 2031, % of Revenue 62
Figure 34. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 63
Figure 35. U.S. Hemodynamic Monitoring Systems Market, 2021-2031, $ mn 65
Figure 36. Canada Hemodynamic Monitoring Systems Market, 2021-2031, $ mn 67
Figure 37. Hemodynamic Monitoring Systems Market in Mexico, 2021-2031, $ mn 69
Figure 38. Growth Stage of North America Hemodynamic Monitoring Systems Industry over the Forecast Period 71
North America hemodynamic monitoring systems market is projected to grow by 6.3% annually in the forecast period and reach $ 826.1 million by 2031, driven by the rising prevalence of cardiovascular diseases & diabetes, increasing geriatric population, the introduction of more innovative and non-invasive devices, extensive research and development (R&D) activities, and the increasing healthcare concerns and expenditure amid COVID-19 pandemic. Highlighted with 21 tables and 38 figures, this 97-page report “North America Hemodynamic Monitoring Systems Market 2021-2031 by Component (Catheters, Sensors, Monitoring Devices, Probes, Others), Modality (Invasive, Minimally Invasive, Non-Invasive), Setting (Hospitals, Clinics, Ambulatory Care Units, Homecare, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America hemodynamic monitoring systems market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and the Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America Hemodynamic monitoring systems market in every aspect of the classification from perspectives of Component, Modality, Setting, and Country. Based on Component, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Catheters • Sensors • Monitoring Devices • Probes • Other Components Based on Modality, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Invasive Monitoring • Minimally Invasive Monitoring • Non-Invasive Monitoring By Setting, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals • Clinics • Ambulatory Care Units • Homecare • Other Settings Geographically, the following national/local markets are fully investigated: • U.S. • Canada • Mexico For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Component, Modality, and Setting over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Baxter International Inc. Caretaker, LLC Cheetah Medical Inc. CN Systems Medizintechnik GmbH Deltex Medical Group PLC Dragerwerk AG & Co. KGaA Edwards Lifesciences Corporation Flosonics Medical GE Healthcare Getinge Group Heart Kinetics ICU Medical Inc. Koninklijke Philips N.V. Lidco Group PLC Masimo Corporation NI Medical Ltd. Osypka Medical GmbH Retia Medical Schwarzer Cardiotek Sramek BioDynamics Inc. Uscom Ltd. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Read More